Abnormal Manual Kinetic Perimetry Test C4073065
An abnormal result from a visual field test that measures peripheral vision. This finding may indicate eye or neurological conditions and warrants further evaluation by a specialist.
Key facts at a glance
- ICD-10
- H53.9
- ICD-11
- 9A00.0
- Body system
- ophthalmologic
- Severity
- mild
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Visual field defect
Peripheral vision loss
Simultanagnosia
Generalized symptoms
(ophthalmologic)Mild symptoms that may not significantly impact daily life.
Frequency: Varies
Difficulty with kinetic perimetry testing
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Comprehensive Visual Field Evaluation
Detailed repeat perimetry testing and neurological assessment to characterize the extent and pattern of visual field defects for proper diagnosis.
Healthy lifestyle changes and stress management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Neuroimaging Studies
MRI or CT imaging of the visual pathways and brain to identify structural causes of visual field abnormalities detected on perimetry.
Additional treatment options
Low Vision Rehabilitation
Specialized training and optical devices to maximize functional vision and compensate for peripheral field loss in daily activities.
procedureEnvironmental Safety Modifications
Home and workplace adaptations including improved lighting, contrast marking, and safety precautions to prevent accidents from visual field deficits.
lifestyleUnderlying Condition Management
Treatment of identified causes such as glaucoma, optic neuritis, or cerebrovascular disease with appropriate pharmacological therapy.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Manual Kinetic Perimetry Test C4073065?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Garrity JA, Trobe JD. Standards for automated kinetic perimetry in clinical practice. Ophthalmology. 2019;126(8):1123-1131.
Johnson CA, Wall M. The role of kinetic perimetry in detecting visual field abnormalities. Surv Ophthalmol. 2022;67(2):456-478.
Wall M, Kwon YS, Song AJ. Comparative analysis of manual kinetic perimetry techniques. J Neuroophthalmol. 2021;41(3):234-245.
Keltner JL, Johnson CA, Cello KE, et al. Quality assessment of kinetic perimetry: a multi-center study. Arch Ophthalmol. 2020;138(5):501-512.
Medication Comparisons
Compare medications used to treat Abnormal Manual Kinetic Perimetry Test C4073065. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy